
About Cancer
Salivary gland cancer is a rare type of head and neck cancer. It starts in one of the salivary glands inside or near your mouth.
The most common symptom of salivary gland cancer is a swelling on the side of the face, just in front of the ear or under the jawbone.
You usually start by seeing your GP and they might refer you to a specialist and organise tests.
The stage of a cancer tells you how big it is and whether it has spread. The TNM staging system is used to stage salivary gland cancer.
The type of salivary gland cancer means the type of cell the cancer started in. Mucoepidermoid carcinomas are the most common type of salivary gland cancer.
Your risk of salivary gland cancer increases with age. Radiation treatment to the head and neck area can also increase your risk.
Survival for salivary gland cancer depends on several factors. These include the type and stage of your cancer.
Treatment for salivary gland cancer depends on where the cancer is, the size, whether it has spread anywhere else and your health.
Find out about the latest UK research looking at salivary gland cancer as well as information about clinical trials.
Getting practical and emotional support can help you to cope with a diagnosis of salivary gland cancer. It can also help you with life during and after treatment.
Last reviewed: 12 May 2023
Next review due: 12 May 2026
This section has been written, reviewed and updated by Cancer Research UK’s Patient Information Web Team. Thanks to the expert medical professionals and people affected by cancer who have helped to review this information.
Professor Christopher Nutting (Consultant Clinical Oncologist)
Our lay reviewers

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.